BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29983259)

  • 1. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
    Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
    Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
    Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
    Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 infection on life expectancy, premature mortality, and DALY in Maharashtra, India.
    Vasishtha G; Mohanty SK; Mishra US; Dubey M; Sahoo U
    BMC Infect Dis; 2021 Apr; 21(1):343. PubMed ID: 33845774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
    Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
    Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
    Barton MB; Delaney GP
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause of death and potentially avoidable deaths in Australian adults with intellectual disability using retrospective linked data.
    Trollor J; Srasuebkul P; Xu H; Howlett S
    BMJ Open; 2017 Feb; 7(2):e013489. PubMed ID: 28179413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 'Catch Up' Plan for radiotherapy in New South Wales to 2012.
    Morgan G; Barton M; Crossing S; Bull C; Penman A
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):419-30. PubMed ID: 19695050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four methods for estimating actual radiotherapy utilisation using the 45 and Up Study cohort in New South Wales, Australia.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Radiother Oncol; 2019 Feb; 131():14-20. PubMed ID: 30773181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability-adjusted life-year burden of abusive head trauma at ages 0-4.
    Miller TR; Steinbeigle R; Wicks A; Lawrence BA; Barr M; Barr RG
    Pediatrics; 2014 Dec; 134(6):e1545-50. PubMed ID: 25404725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality among a Cohort of Persons with an Intellectual Disability in New South Wales, Australia.
    Florio T; Trollor J
    J Appl Res Intellect Disabil; 2015 Sep; 28(5):383-93. PubMed ID: 25994286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009.
    de Blank PM; Ostrom QT; Rouse C; Wolinsky Y; Kruchko C; Salcido J; Barnholtz-Sloan JS
    Cancer Med; 2015 Apr; 4(4):608-19. PubMed ID: 25627000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
    Degenhardt L; Larney S; Randall D; Burns L; Hall W
    Addiction; 2014 Jan; 109(1):90-9. PubMed ID: 23961881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential gains in life expectancy or years of potential life lost: impact of competing risks of death.
    Lai D; Hardy RJ
    Int J Epidemiol; 1999 Oct; 28(5):894-8. PubMed ID: 10597988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the use of RT in NSW: a qualitative study exploring consumer and health professional perspectives.
    Sundaresan P; Milross CG; Smith A; Evans A; Stockler MR; King MT
    J Med Imaging Radiat Oncol; 2014 Oct; 58(5):625-32. PubMed ID: 24945988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
    Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
    Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of radiotherapy for lung cancer in New South Wales, Australia.
    Vinod SK; Simonella L; Goldsbury D; Delaney GP; Armstrong B; O'Connell DL
    Cancer; 2010 Feb; 116(3):686-94. PubMed ID: 19957325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Years of potential life lost and valued years of potential life lost in assessing premature mortality in Slovenia.
    Semerl JS; Sesok J
    Croat Med J; 2002 Aug; 43(4):439-45. PubMed ID: 12187522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.